Catalyst Wire Dossier Catalyst Wire Dossier

Zanamivir (Relenza)

Zanamivir · GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Zanamivir (Relenza), covering 2013-01-16 to 2013-01-16. Get the full timeline:

Most recent: Clinical Trial Update: Efficacy and Safety of Inhaled Zanamivir in Treatment of Influenza A and B Virus Infections in China [Phase 3]

See pricing